-
5
-
-
0024294399
-
-
d) D. A. Evans, Science 1989, 240, 420;
-
(1989)
Science
, vol.240
, pp. 420
-
-
Evans, D.A.1
-
6
-
-
0000235486
-
-
e) T. Shibata, H. Morioka, T. Hayase, K. Choji, K. Soai, J. Am. Chem. Soc. 1996, 118, 471-472, and references therein.
-
(1996)
J. Am. Chem. Soc.
, vol.118
, pp. 471-472
-
-
Shibata, T.1
Morioka, H.2
Hayase, T.3
Choji, K.4
Soai, K.5
-
7
-
-
0001806088
-
-
a) T. Mukaiyama, K. Suzuki, K. Soai, T. Sato, Chem. Lett. 1979, 447-448;
-
(1979)
Chem. Lett.
, pp. 447-448
-
-
Mukaiyama, T.1
Suzuki, K.2
Soai, K.3
Sato, T.4
-
13
-
-
0028785708
-
-
a) S. D. Young, S. F. Britcher, L. O. Tran, L. S. Payne, W. C. Lumma, T. A. Lyle, J. R. Huff, P. S. Anderson, D. B. Olsen, S. S. Carrol, D. J. Pettibone, J. A. O'Brien, R. G. Ball, S. K. Balani, J. H. Lin, I.-W. Chen, W. A. Schleif, V. V. Sardana, W. J. Long, V. W. Byrnes, E. A. Emini, Antimicrob. Agents Chemother. 1995, 39, 2602;
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 2602
-
-
Young, S.D.1
Britcher, S.F.2
Tran, L.O.3
Payne, L.S.4
Lumma, W.C.5
Lyle, T.A.6
Huff, J.R.7
Anderson, P.S.8
Olsen, D.B.9
Carrol, S.S.10
Pettibone, D.J.11
O'Brien, J.A.12
Ball, R.G.13
Balani, S.K.14
Lin, J.H.15
Chen, I.-W.16
Schleif, W.A.17
Sardana, V.V.18
Long, W.J.19
Byrnes, V.W.20
Emini, E.A.21
more..
-
14
-
-
15644376567
-
Durable Clinical Anti-HIV-1 Activity and Tolerability for DMP-266 in Combination with Indinavir (IDV) at 24 Weeks
-
Clinical data presented Toronto
-
b) D. Mayers, S. Riddler, M. Bach, D. Stein, M. D. Havlir, J. Kahn, N. Ruiz, D. F. Labriola, and the DMP-266 clinical development team, Clinical data presented at the ICAAC meeting (Toronto) 1997, I-175, Durable Clinical Anti-HIV-1 Activity and Tolerability for DMP-266 in Combination with Indinavir (IDV) at 24 Weeks.
-
(1997)
ICAAC Meeting
-
-
Mayers, D.1
Riddler, S.2
Bach, M.3
Stein, D.4
Havlir, M.D.5
Kahn, J.6
Ruiz, N.7
Labriola, D.F.8
-
15
-
-
0028788312
-
-
A. S. Thompson, E. G. Corley, M. F. Huntington, E. J. J. Grabowski, Tetrahedron Lett. 1995, 36, 8937-8940.
-
(1995)
Tetrahedron Lett.
, vol.36
, pp. 8937-8940
-
-
Thompson, A.S.1
Corley, E.G.2
Huntington, M.F.3
Grabowski, E.J.J.4
-
16
-
-
0032507282
-
-
a) A. S. Thompson, E. G. Corley, M. F. Huntington, E. J. J. Grabowski, J. F. Remenar, D. B. Collum, J. Am. Chem. Soc. 1998, 120, 2028-2038;
-
(1998)
J. Am. Chem. Soc.
, vol.120
, pp. 2028-2038
-
-
Thompson, A.S.1
Corley, E.G.2
Huntington, M.F.3
Grabowski, E.J.J.4
Remenar, J.F.5
Collum, D.B.6
-
17
-
-
33747558420
-
-
personal communication
-
b) Feng Xu (Merck), personal communication.
-
-
-
Xu, F.1
-
18
-
-
85012338949
-
-
submitted
-
D. Zhao, C.-Y. Chen, F. Xu, L. Tan, R. D. Tillyer, M. E. Pierce, J. R. Moore, Org. Synth., submitted.
-
Org. Synth.
-
-
Zhao, D.1
Chen, C.-Y.2
Xu, F.3
Tan, L.4
Tillyer, R.D.5
Pierce, M.E.6
Moore, J.R.7
-
19
-
-
0000462955
-
-
a) A similar species has been reported: D. Enders, J. Zhu, G. Raabe, Angew. Chem. 1996, 108, 1827;
-
(1996)
Angew. Chem.
, vol.108
, pp. 1827
-
-
Enders, D.1
Zhu, J.2
Raabe, G.3
-
20
-
-
0029785064
-
-
13C NMR studies of the solution showed a very complicated system. The observed chiral amplification supported the formation of dimer or higher order aggregates: the enantiomeric excess of the product was 97.5, 94.4, and 79.6%, respectively, when (1R,2S)-N-pyrrolidinylnorephedrine with 100, 80, and 50% ee was used for the reaction at room temperature.
-
(1996)
Angew. Chem. Int. Ed. Engl.
, vol.35
, pp. 1725-1728
-
-
-
21
-
-
33747523834
-
-
note
-
The enantiomeric excess was determined by HPLC assay on a chiralcel-AD column (hexane/isopropyl alcohol, 3/1)
-
-
-
-
22
-
-
33747541654
-
-
note
-
Trifluoroethanol is preferred to neopentyl alcohol because it gives a faster reaction.
-
-
-
-
23
-
-
33747560691
-
-
note
-
3 (%): C 47.88, H 3.71, N 4.29; found: C 48.14, H 3.39, N 4.15.
-
-
-
-
24
-
-
33747568218
-
-
note
-
3 (%): C 53.80, H 3.77, N 4.72; found: C 53.67, H 3.80, N 4.67.
-
-
-
-
25
-
-
33747574645
-
-
note
-
2 (%): C 56.87, H 3.27, N 3.49; found: C 56.99, H 2.98, N 3.42.
-
-
-
|